Association of Extended Dosing Intervals or Delays in Pembrolizumab-Based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)
Heather Brody (Creator)
Anushi Bulumulle (Creator)
Cynthia R. Cherry (Creator)
Daniel B. Costa (Creator)
Ritu R. Gill (Creator)
Mark S. Huberman (Creator)
Shravanti Macherla (Creator)
Danielle C. McDonald (Creator)
Aleksandra Qilleri (Creator)
Deepa Rangachari (Creator)
Kartik Sehgal (Creator)
Meghan Shea (Creator)
Paul A. VanderLaan (Creator)
Paul R. Walker (Creator)
Glen J. Weiss (Creator)
Institution
East Carolina University (ECU )
Web Site: http://www.ecu.edu/lib/

Additional Information

Publication
Other
Language: English
Date: 2023
Subjects
Dosing Intervals;Survival Outcomes;Nonesmall-cell Lung Cancer

Email this document to

This item references:

TitleLocation & LinkType of Relationship
Association of Extended Dosing Intervals or Delays in Pembrolizumab-Based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancerhttp://hdl.handle.net/10342/11510The described resource references, cites, or otherwise points to the related resource.